Barrett's esophagus (disorder)

Clinical Trial: AspECT

Year Started: 2005

AspECT: A Phase III, Randomised Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia. Trial has 10-year follow up period with samples collected throughout. Patient age groups given in the Sample Sets are the age of the patients at trial randomisation



Access:
Open to applicants
Type:
Clinical Trial
Status:
Completed
Consent restrictions:
Commercial restriction, DNA restriction


Associated Data Type Procurement Timeframe
Followup records 0 - 3 months
Pathology records 3 - 6 months
Physiological/biochemical measurements 0 - 3 months
Treatment records 0 - 3 months


Female

Adult (> 40 years)

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Tissue specimen Surgical procedure (procedure) RT Paraffin Affected 51 - 75%
Whole blood -60°C to -85°C N/A Not applicable 51 - 75%


Female

Young adult (18 - 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Tissue specimen Surgical procedure (procedure) RT Paraffin Affected 51 - 75%
Whole blood -60°C to -85°C N/A Not applicable 51 - 75%

Malignant tumor of ovary (disorder)

Clinical Trial: 6MP

Year Started: 2011

See clinicaltrials.gov record NCT01432145 for more information about the study. Whole blood and plasma samples collected pre and post treatment in approx 70 participants and associated FFPE tumour tissue for approx 25 participants. Study data also available on request.



Access:
Open to applicants
Type:
Disease specific
Status:
Completed
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
There is no associated data for this collection.


Female

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Plasma -60°C to -85°C N/A Not applicable 0 - 10%
Tissue specimen Surgical procedure (procedure) RT N/A Not applicable 0 - 10%
Whole blood -60°C to -85°C N/A Not applicable 0 - 10%